Court dismisses part of Lilly lawsuit against Empower, some claims can proceed

April 30, 2026 02:16 PM EDT PharmaLawGLP-1 drugs Court dis­miss­es part of Lil­ly law­suit against com­pounder Em­pow­er, but some claims can pro­ceed Shelby Livingston Health tech correspondent A fed­er­al judge has dis­missed part of Eli Lil­ly’s law­suit al­leg­ing Em­pow­er Phar­ma­cy mis­led cus­tomers about its com­pound­ed ver­sions of the obe­si­ty drug tirzepatide. But … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER